Health Desk- 01 March,
2020: Tianjin University has successfully developed an oral vaccine to
protect against novel coronavirus pneumonia (COVID-19). Huang Jinhai, the
professor who led the project, has himself taken four doses and has not
experienced any side effects. The university is now looking for partners to
promote clinical trials and broad usage, reports Global Times, an
English-language Chinese newspaper.
The oral vaccine uses food-grade saccharomyces cerevisiae as
a carrier and the spike protein of the coronavirus as a target spot to produce
antibodies to fight COVID-19, according to a statement Tianjin University sent
to the Global Times on Tuesday.
Huang’s team has produced samples of the oral vaccine in the
form of capsules, milk tablets and granular formulations. They have also
developed core technologies in recombinant strains construction, selection, protein
expression and fermentation dynamics, which are critical to the vaccine’s
development, the statement noted.
Huang said the vaccine, taken orally, could stimulate local
mucosal immunization to prevent infection. It could also serve as a potential
therapy for infected patients to combat the coronavirus.
http://amarhealth.com/pharmaceuticals/4745/TianjinUniversitydevelopsvaccine
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন